The Europe malaria treatment market is expected to grow from US$ 593.03 million in 2022 to US$ 785.75 million by 2028. It is estimated to register a CAGR of 4.8% from 2022 to 2028.
AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, and Zydus Healthcare Ltd are among the leading companies operating in the Europe malaria treatment market.
Extending Pipeline of New Drugs and Vaccines is Driving the Europe Malaria Treatment Market
Antimicrobial resistance threatens the public health response to many diseases, such as malaria, and the R&D of new medicines is the best strategy to overcome this challenge. With this, the antimalarial drug/vaccine pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities in the malaria treatment market, creating lucrative opportunities for the market growth. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, is working with many pharmaceutical companies to reduce the burden of malaria by developing novel treatment options. In December 2019, Ipca Laboratories collaborated with MMV to develop Atoguanil, a novel antimalarial coformulation. So, extending pipeline of new drugs and vaccines is expected to drive the Europe malaria treatment market .Europe Malaria Treatment Market Overview
The Europe malaria treatment market includes the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022. According to the European Center for Disease Prevention and Control report, in 2019, 8,641 malaria cases were registered in the European Union (EU), among which 8,638 (>99%) were malaria-confirmed cases. Additionally, 5,509 cases (99.8%) of malaria cases were travel-related, among which two were registered in Germany. The cases in Germany were infected by vector-borne transmission. The EU supports eradicating malaria by aiming to facilitate the development and producing a highly efficacious malaria vaccine. For example, in July 2021, backed by the eradicate Malaria initiative, German company BioNTech announced a malaria project focusing on developing an mRNA-based vaccine against the disease and evaluating mRNA vaccine production in Africa. Moreover, in September 2022, Germany signed an agreement worth US$ 1.34 billion with The Joint United Nations Programme on HIV/AIDS (UNAIDS), aiming to fight AIDS, tuberculosis, and malaria with an increase of 30% of the country's contribution from 2019. Further, from 2010 to 2020, international sources provided 69% of total funding aiming for malaria control and elimination, as per the endmalaria.org 2020 report. For example, total funding for malaria control and elimination accounted for US$ 3.3 billion; Germany contributed US$ 0.2 billion.Europe Malaria Treatment Market Segmentation
The Europe malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.- Based on treatment, the Europe malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is further categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.
- Based on drug type, the Europe malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.
- Based on route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.
- Based on distribution channel, the Europe malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.
- Based on end user, the Europe malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The hospitals segment held the largest market share in 2022.
- Based on country, the Europe malaria treatment market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany dominated the market in 2022.
AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, and Zydus Healthcare Ltd are among the leading companies operating in the Europe malaria treatment market.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Malaria Treatment Market - By Treatment
1.3.2 Europe Malaria Treatment Market - By Drug Type
1.3.3 Europe Malaria Treatment Market - By Route of Administration
1.3.4 Europe Malaria Treatment Market - By Distribution Channel
1.3.5 Europe Malaria Treatment Market - By End User
1.3.6 Europe Malaria Treatment Market- By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Malaria Treatment Market- Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Malaria Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Government and Private Sector’s Initiatives to Raise Awareness About Malaria
5.2 Market Restraints
5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Extending Pipeline of New Drugs and Vaccines
5.4 Future Trends
5.4.1 Rapid Diagnostic Tests
5.5 Impact Analysis
6. Malaria Treatment Market- Europe Analysis
6.1 Europe Malaria Treatment Market Revenue Forecast and Analysis
7. Europe Malaria Treatment Market Analysis - By Treatment
7.1 Overview
7.2 Europe Malaria Treatment Market, By Treatment 2021 & 2028 (%)
7.3 Prescription Medications
7.3.1 Overview
7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Chloroquine Phosphate
7.3.3.1 Overview
7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.4 Artemisinin- based Combination Therapies (ACTs)
7.3.4.1 Overview
7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
7.3.5 Atovaquone-Proguanil
7.3.5.1 Overview
7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
7.3.6.1 Overview
7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
7.3.7 Primaquine Phosphate
7.3.7.1 Overview
7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Vaccines
7.4.1 Overview
7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Diagnostic Tests
7.5.1 Overview
7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8. Europe Malaria Treatment Market Analysis - By Drug Type
8.1 Overview
8.2 Europe Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
8.3 Branded
8.3.1 Overview
8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Generics
8.4.1 Overview
8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Malaria Treatment Market Analysis - By Route of Administration
9.1 Overview
9.2 Europe Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
9.3 Oral
9.3.1 Overview
9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Parenteral and Intravenous Mode
9.4.1 Overview
9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Malaria Treatment Market Analysis - By Distribution Channel
10.1 Overview
10.2 Europe Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
10.3 Direct Tender
10.3.1 Overview
10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Retail Pharmacies
10.5.1 Overview
10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Online Pharmacies
10.6.1 Overview
10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Malaria Treatment Market Analysis - By End User
11.1 Overview
11.2 Europe Malaria Treatment Market, By End User 2021 & 2028 (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Specialty Clinics
11.4.1 Overview
11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Homecare
11.5.1 Overview
11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
11.6.1 Overview
11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
12. Europe Malaria Treatment Market - Country Analysis
12.1 Overview
12.1.2 Europe: Malaria Treatment Market, by Country, 2021 & 2028 (%)
12.1.2.1 Germany: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 Overview
12.1.2.1.2 Germany: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 Germany: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3.1 Germany: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.1.4 Germany: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.5 Germany: Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.6 Germany: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.7 Germany: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2 France: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.1 Overview
12.1.2.2.2 France: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 France: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3.1 France: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.2.4 France: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.5 France: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.6 France: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.7 France: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3 UK: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.1 Overview
12.1.2.3.2 UK: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 UK: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3.1 UK: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.3.4 UK: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.5 UK: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.6 UK: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.7 UK: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4 Italy: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.1 Overview
12.1.2.4.2 Italy: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.3 Italy: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.3.1 Italy: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.4.4 Italy: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.5 Italy: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.6 Italy: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.7 Italy: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5 Spain: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.1 Overview
12.1.2.5.2 Spain: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.3 Spain: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.3.1 Spain: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.5.4 Spain: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.5 Spain: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.6 Spain: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.5.7 Spain: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6 Rest of Europe: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.1 Overview
12.1.2.6.2 Rest of Europe: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.3 Rest of Europe: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.3.1 Rest of Europe: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
12.1.2.6.4 Rest of Europe: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.5 Rest of Europe: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.6 Rest of Europe: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
12.1.2.6.7 Rest of Europe: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 Zydus Healthcare Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sun Pharmaceutical Industries Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi SA
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GSK Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Cipla Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Viatris Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Lupin Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AdvaCare Pharma USA LLC
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
Table 1. Europe Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. UK: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 18. UK: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 27. Spain: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Europe: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Europe: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of Europe: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 38. Recent Inorganic Growth Strategies
Table 39. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 40. Glossary of Terms
Figure 1. Europe Malaria Treatment Market Segmentation
Figure 2. Europe Malaria Treatment Market Segmentation, By Country
Figure 3. Europe Malaria Treatment Market Overview
Figure 4. Europe Malaria Treatment Market, By Distribution Channel
Figure 5. Europe Malaria Treatment Market, By Country
Figure 6. Europe and PEST Analysis
Figure 7. Europe Malaria Treatment Market impact analysis of driver and restraints
Figure 8. Europe Malaria Treatment Market - Revenue Forecast and Analysis
Figure 9. Europe Malaria Treatment Market, by Treatment 2021 & 2028 (%)
Figure 10. Prescription Medication: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Chloroquine Phosphate: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Artemisinin- based Combination Therapies (ACTs): Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Atovaquone-Proguanil: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Primaquine Phosphate: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Others: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Vaccines: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Diagnostic Tests: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Others: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Europe Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
Figure 21. Branded: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Generics: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Europe Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
Figure 24. Oral: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Parenteral and Intravenous Mode: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Europe Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
Figure 27. Direct Tender: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Hospital Pharmacies: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Retail Pharmacies: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Online Pharmacies: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Others: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Europe Malaria Treatment Market, by End User 2021 & 2028 (%)
Figure 33. Hospitals: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Specialty Clinics: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Homecare: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Others: Europe Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. Europe: Malaria Treatment Market, by Key Country - Revenue (2021) (US$ Million)
Figure 38. Europe: Malaria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. Germany: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. France: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. UK: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Italy: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Spain: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Rest of Europe: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AdvaCare Pharma USA LLC
- Cipla Ltd
- GSK Plc
- Lupin Ltd
- Novartis AG
- Sanofi SA
- Sun Pharmaceutical Industries Ltd
- Viatris Inc
- Zydus Healthcare Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 151 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 593.03 Million |
| Forecasted Market Value ( USD | $ 785.75 Million |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Europe |
